These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27324698)

  • 1. Physicochemical characterization of biopharmaceuticals.
    Parr MK; Montacir O; Montacir H
    J Pharm Biomed Anal; 2016 Oct; 130():366-389. PubMed ID: 27324698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization.
    Sandra K; Vandenheede I; Sandra P
    J Chromatogr A; 2014 Mar; 1335():81-103. PubMed ID: 24365115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some considerations regarding drug determinations in biological fluids with physico-chemical methodologies [proceedings].
    De Graeve J
    Ann Biol Clin (Paris); 1978; 36(3):161-8. PubMed ID: 360889
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in native high-performance liquid chromatography and intact mass spectrometry for the characterization of biopharmaceutical products.
    Tassi M; De Vos J; Chatterjee S; Sobott F; Bones J; Eeltink S
    J Sep Sci; 2018 Jan; 41(1):125-144. PubMed ID: 28990739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical Aspects of Biopharmaceuticals and their Study by Mass Spectrometry.
    David V; Borbala D; Laroly V; Laszlo D; Istvan A; Imre K; Krisztina L
    Acta Pharm Hung; 2016; 86(4):141-150. PubMed ID: 29870600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sweet spot for biologics: recent advances in characterization of biotherapeutic glycoproteins.
    O'Flaherty R; Trbojević-Akmačić I; Greville G; Rudd PM; Lauc G
    Expert Rev Proteomics; 2018 Jan; 15(1):13-29. PubMed ID: 29130774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis.
    Lingg N; Zhang P; Song Z; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1462-72. PubMed ID: 22829536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
    Bronsema KJ; Bischoff R; van de Merbel NC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Immunogenicity of Biopharmaceuticals.
    Pineda C; Castañeda Hernández G; Jacobs IA; Alvarez DF; Carini C
    BioDrugs; 2016 Jun; 30(3):195-206. PubMed ID: 27097915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.
    Kaltashov IA; Bobst CE; Pawlowski J; Wang G
    J Pharm Biomed Anal; 2020 May; 184():113169. PubMed ID: 32092629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cells.
    Lebrec H; Narayanan P; Nims R
    J Appl Toxicol; 2010 Jul; 30(5):387-96. PubMed ID: 20589744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in LC-MS based characterization of protein-based bio-therapeutics - mastering analytical challenges posed by the increasing format complexity.
    Graf T; Heinrich K; Grunert I; Wegele H; Haberger M; Bulau P; Leiss M
    J Pharm Biomed Anal; 2020 Jul; 186():113251. PubMed ID: 32251978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays.
    Bults P; van de Merbel NC; Bischoff R
    Expert Rev Proteomics; 2015 Aug; 12(4):355-74. PubMed ID: 26005069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.
    Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y
    MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expediting online liquid chromatography for real-time monitoring of product attributes to advance process analytical technology in downstream processing of biopharmaceuticals.
    Graf T; Naumann L; Bonnington L; Heckel J; Spensberger B; Klein S; Brey C; Nachtigall R; Mroz M; Hogg TV; McHardy C; Martinez A; Braaz R; Leiss M
    J Chromatogr A; 2024 Aug; 1729():465013. PubMed ID: 38824753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of glycosylation analysis in development of biopharmaceuticals.
    Kawasaki N; Itoh S; Hashii N; Takakura D; Qin Y; Huang X; Yamaguchi T
    Biol Pharm Bull; 2009 May; 32(5):796-800. PubMed ID: 19420744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of current mass spectrometry in pharmaceutical analysis?
    Khalikova M; Jireš J; Horáček O; Douša M; Kučera R; Nováková L
    Mass Spectrom Rev; 2024; 43(3):560-609. PubMed ID: 37503656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product.
    Liu C; Dong S; Xu XJ; Yin Y; Shriver Z; Capila I; Myette J; Venkataraman G
    J Pharm Biomed Anal; 2011 Jan; 54(1):27-36. PubMed ID: 20800406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosimilars--science, status, and strategic perspective.
    Kresse GB
    Eur J Pharm Biopharm; 2009 Aug; 72(3):479-86. PubMed ID: 19286455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.